TG Therapeutics, Inc. (TGTX)
39.93
+0.20
(+0.50%)
USD |
NASDAQ |
May 27, 15:01
TG Therapeutics Cash from Investing (Quarterly) : -9.864M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Krystal Biotech, Inc. | -63.58M |
| Precision BioSciences, Inc. | -0.114M |
| AnaptysBio, Inc. | 34.98M |
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| Geron Corp. | 51.86M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.89M |
| Cash from Financing (Quarterly) | 390.83M |
| Free Cash Flow | -14.19M |
| Free Cash Flow Per Share (Quarterly) | -0.1121 |
| Free Cash Flow to Equity (Quarterly) | -517.79M |
| Free Cash Flow to Firm (Quarterly) | -10.50M |
| Free Cash Flow Yield | -0.22% |